- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04951310
COVID-19 Vaccinations With a Sweepstakes
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All 18+ residents of the City of Philadelphia will be eligible. Residents will be able to win the sweepstakes prizes if they can verify they received at least one dose of the COVID-19 vaccine before the date of the sweepstakes drawing in question.
Exclusion Criteria:
- None.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
No Intervention: Control participants (residents of Bucks County, Montgomery County, Delaware County, and Allegheny County, PA) are not eligible for the sweepstakes.
|
|
Experimental: Selected Zip Code Treatment
Selected Zip Code Treatment participants will have a significantly greater chance to win a prize in the sweepstakes than all other Philadelphia residents.
Half of all prizes in every drawing will go to Philadelphia residents in the selected zip code.
|
The "Philly Vax Sweepstakes" is a citywide sweepstakes designed to motivate Philadelphians to get vaccinated against COVID-19.
A total of 36 vaccinated Philadelphians will win among three cash prize packages, distributed from the total cash pool.
These 36 will be chosen over three drawings, with 12 residents chosen in each drawing.
|
Experimental: All other Philadelphia Residents Treatment
All other Philadelphia Residents Treatment participants will be eligible for the sweepstakes.
Half of all prizes in every drawing will go to Philadelphia residents outside of the selected zip code.
|
The "Philly Vax Sweepstakes" is a citywide sweepstakes designed to motivate Philadelphians to get vaccinated against COVID-19.
A total of 36 vaccinated Philadelphians will win among three cash prize packages, distributed from the total cash pool.
These 36 will be chosen over three drawings, with 12 residents chosen in each drawing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weekly Vaccination Rate
Time Frame: 15 Weeks
|
The primary outcome is the weekly vaccination rate for residents receiving a first dose of a COVID-19 vaccination in each zip/county/city as measured by local health departments and, for residency, as measured by the Census or other official sources. The investigators will include data from 5 weeks of pre-intervention, 6 weeks of intervention, and 4 weeks of post-intervention. Weekly Vaccination Rate = Total residents receiving a first dose that week / Total residents in that zip/county/city code as measured by the Census or other official sources, at the most recent date available for all geographies of interest. This source as of pre-registering is the American Community Survey 2019. |
15 Weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 849044
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichEnrolling by invitation
-
Alexandria UniversityCompleted
Clinical Trials on Philly Vax Sweepstakes
-
Philadelphia Department of Public HealthChildren's Hospital of Philadelphia; Stanford UniversityCompletedHealth BehaviorUnited States
-
Chonnam National University HospitalUnknownMultiple MyelomaKorea, Republic of
-
University of OxfordCancer Institute and Hospital, Chinese Academy of Medical Sciences; Qidong... and other collaboratorsCompletedLiver Diseases | Hepatitis B | Liver NeoplasmsUnited Kingdom, China
-
Entos Pharmaceuticals Inc.Canadian Institutes of Health Research (CIHR); Aegis Life, Inc.; Clinical Pharma... and other collaboratorsCompletedSARS-CoV-2Burkina Faso, Canada, Senegal, South Africa
-
Baiya Phytopharm Co., Ltd.National Vaccine Institute, ThailandActive, not recruiting
-
Lazarski UniversityThe Cleveland Clinic; Wroclaw Medical UniversityCompletedUltrasonography | Optic Nerve Sheath DiameterPoland
-
Uppsala UniversityKarolinska Institutet; Cyto Pulse Sciences, Inc.Completed
-
Vaxcyte, Inc.Active, not recruitingPneumococcal VaccinesUnited States
-
National University Hospital, SingaporeUnknown
-
Icahn School of Medicine at Mount SinaiUnknownMultiple Myeloma | Hodgkin's Disease | Chronic Lymphocytic Lymphoma | Relapsed Non-Hodgkin's LymphomaUnited States